The adjuvant effect of polymuramil, a NOD1 and NOD2 agonist, differs when immunizing mice of different inbred lines with nonstructural hepatitis C virus (Flaviviridae: &lt;i&gt;Hepacivirus&lt;/i&gt;)proteins and is synergistically enhanced in combination with pyrogenalum, a TLR4 agonist
Voprosy virusologii